Zemits JoliPeel

The Zemits JoliPeel is a compact, portable 2-in-1 system that combines diamond microdermabrasion with serum application in one device. It delivers gentle, customizable mechanical resurfacing plus deeper serum infusion, and is built specifically for professional estheticians. It addresses fine lines, acne scars, hyperpigmentation and dull skin - so it is a resurfacing and product-delivery platform rather than an energy-based lifting device. **Key points:** - Modality: diamond-tip microdermabrasion (mechanical exfoliation) combined with serum application/infusion. - Indications named in the listing: fine lines, acne scars, hyperpigmentation and dull skin. - Control: the listing describes the resurfacing as gentle and customizable, so treatment intensity can be dialled to the client's skin and sensitivity. - Positioned for professional estheticians working in salon or clinical settings, not for home use. - Two capabilities in one chassis means fewer devices and a shorter treatment sequence than running separate exfoliation and infusion equipment. **Business case:** A 2-in-1 microdermabrasion plus infusion system is the most service-flexible purchase in this category per unit of capital: the same device supports a basic resurfacing facial, an anti-aging infusion protocol and a prep step before needling or RF, so one unit feeds several menu items and reduces the risk of an under-used single-purpose machine. **Confidence:** High - modality, indications, control behaviour and professional positioning are all stated in the product record. **Evidence source:** Product listing `zemits-jolipeel` (id=1086), fields: lede, what_it_is, how_it_works, who_for.

The regulatory status of the Zemits JoliPeel cannot be confirmed from the current product data. The structured fields `fda_key`, `fda_label` and `fda_tone` are empty on the product record and the listing text contains no FDA clearance, CE marking or equivalent certification claim. No conclusion can be drawn about either clearance or non-clearance. **Key points:** - `fda_key`, `fda_label` and `fda_tone` are all empty. - No regulatory statement appears anywhere in the lede, what_it_is, how_it_works or who_for fields. - Diamond microdermabrasion devices are often marketed as aesthetic/cosmetic equipment rather than as cleared medical devices - which means the regulatory burden varies by jurisdiction, and in the US a cosmetic-only positioning may mean no FDA clearance exists at all rather than that it was simply not published. - The listing describes professional esthetician use only; it does not make any medical or therapeutic claim. **⚠️ FLAG - procurement verification required.** Before purchase, obtain from the supplier: (1) written confirmation of whether any FDA 510(k) clearance exists and, if so, the number and cleared indication, (2) CE marking documentation to EU MDR 2017/745 or UKCA evidence if sold into Europe, (3) a signed regulatory status letter on company letterhead stating whether the device is marketed as cosmetic or medical equipment in your jurisdiction, (4) IEC 60601-1 electrical safety certification and a consumable/tip availability commitment for the expected service life of the device. **Business case:** Microdermabrasion sits in a grey zone between cosmetic and medical claims in many markets - knowing which side your supplier positions it on determines what you are legally allowed to advertise and whether the service is insurable. **Confidence:** Low - no FDA or equivalent regulatory information of any kind is present in the product data, so no status can be stated. **Evidence source:** Product listing `zemits-jolipeel` (id=1086), fields: fda_key, fda_label, fda_tone, lede, what_it_is, how_it_works, who_for (all regulatory fields empty).

The product record describes the resurfacing-plus-infusion mechanism but publishes no session count or interval schedule. Use the standard diamond microdermabrasion protocol for this device class and confirm the exact schedule with the manufacturer: a course of 6-10 sessions spaced 1-2 weeks apart, then maintenance every 4-6 weeks. **Key points:** - Course: 6-10 sessions at 1-2 week intervals - microdermabrasion results are cumulative and depend on treatment density more than on any single session. - Customisation: the listing states the resurfacing is gentle and customizable, so the pass count and tip choice are set to the client's skin condition and sensitivity rather than fixed. - Downtime: minimal; expect mild transient redness for a few hours. Clients can usually return to work the same day, which supports a lunchtime service. - Maintenance: one session every 4-6 weeks sustains the exfoliation and infusion benefit. - Post-treatment: broad-spectrum SPF is mandatory and active exfoliants should be paused for 48-72 hours, especially when the same session included a deeper serum infusion. **Business case:** Microdermabrasion's short session time and low downtime make it the ideal 'always-on' volume service that keeps treatment rooms busy between high-ticket HIFU or RF bookings, and the serum-infusion capability lets you attach a retail product sale to every session. **Confidence:** Medium - the mechanism, customisability and clinical setting are product-documented; the specific session counts and intervals are standard clinical practice for microdermabrasion rather than published device specifications. **Evidence source:** Product listing `zemits-jolipeel` (id=1086), fields: lede, what_it_is, how_it_works, who_for.

The listing records the treatment indications - fine lines, acne scars, hyperpigmentation and dull skin - but publishes no Fitzpatrick skin-type restriction or contraindication table. Diamond microdermabrasion is mechanical rather than thermal, so the main risk in darker skin is abrasive irritation and post-inflammatory hyperpigmentation (PIH) from overly aggressive passes, not heat injury. **Key points:** - No Fitzpatrick range or skin-type claim appears in the product record. - Fitzpatrick V-VI: reduce the number of passes rather than increasing pressure, use the finest diamond tip for a first session and space sessions further apart; abrasive trauma can trigger PIH. - Because the device also infuses serum, check the ingredient list of any infused product for irritants or photosensitisers before use on reactive or darker skin. - Screen for and document: active acne or infection in the treatment area, recent chemical peel or isotretinoin use, rosacea in a flare, anticoagulant therapy, keloid tendency and pregnancy. - Skin-type screening differs by modality in this category: only Goldskin Fractional Micro Needle RF (id=685) carries an explicit all-skin-types-and-tones statement - this device does not. **Business case:** Microdermabrasion is often sold as 'safe for everyone', and that assumption is exactly what produces PIH complaints. A documented Fitzpatrick-based parameter plan is what makes the service defensible if a client complains about pigmentation afterwards. **Confidence:** Low to Medium - the absence of any skin-type claim is confirmed from the record; the Fitzpatrick V-VI guidance is standard clinical practice for microdermabrasion, not a product-documented specification. **Evidence source:** Product listing `zemits-jolipeel` (id=1086), fields: lede, what_it_is, how_it_works, who_for; cross-reference `goldskin-fractional-radiofrequency-for-face-and-body` (id=685), field: who_for.